Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The process begins with an initial consultation where the provider assesses the individuals health status and determines if they are a suitable candidate for treatment
A dedicated Phase 2b trial in MASLD and MASH patients is currently ongoing, with Phase 3 studies planned
Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function
Here is why patients trust us: NABH accredited tertiary care hospital NABL accredited laboratory services International quality standards and protocols Advanced diagnostic and treatment facilities Multidisciplinary team approach Patient centric care model Our specialists use evidence based strategies to help manage diabetes, obesity, and metabolic conditions safely and effectively
Partnering with a clinician will help guide you in making the best choice and aid you in setting expectations for what successful treatment looks like at 3, 6, and 12 monthsand beyond
US$ 28.83
US$ 26.21
US$ 28.98
US$ 25.15
